Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amyloidosis: a changing clinical perspective.

Peter Jacobs1, Paul Ruff, Lucille Wood

  • 1College of Medicine - University of Nebraska Medical School, Nebraska, USA.

Hematology (Amsterdam, Netherlands)
|April 25, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Participants with long-chain 3-hydroxy-acylCoA dehydrogenase deficiency (LCHADD)/trifunctional protein deficiency (TFPD) report consistent low-fat diet intake over time.

Molecular genetics and metabolism·2026
Same author

Combinatorial drug repurposing of Valproic acid and Zebularine regulates Krüppel-like factor 4 and β-catenin expression in colon cancer cells.

PloS one·2026
Same author

A generalizable cross-continent prediction of esophageal squamous cell carcinoma using the oral microbiome.

Communications medicine·2026
Same author

Overall survival, poverty differentials, and mediating pathways among women with breast cancer: South African Breast Cancer and HIV Outcomes cohort.

The oncologist·2025
Same author

A generalizable cross-continent prediction of esophageal squamous cell carcinoma using the oral microbiome.

bioRxiv : the preprint server for biology·2025
Same author

Measuring dietary intake among participants with a urea cycle disorder using standard diet records or a novel food photography app.

Molecular genetics and metabolism·2025

Primary amyloidosis, a plasma cell disorder, involves abnormal immunoglobulin light chain buildup in organs, causing damage. It is linked to underlying lymphoplasmacytoid neoplasms, with potential progression to multiple myeloma.

Area of Science:

  • Hematology
  • Nephrology
  • Oncology

Background:

  • Primary amyloidosis is a plasma cell dyscrasia characterized by abnormal immunoglobulin light chain deposition.
  • These deposits accumulate in vital organs such as kidneys, heart, and liver, leading to organ damage.
  • The disease is associated with an underlying lymphoplasmacytoid neoplasm, detectable in serum and bone marrow.

Purpose of the Study:

  • To describe the characteristics of primary amyloidosis.
  • To highlight the association with lymphoplasmacytoid neoplasms.
  • To note the potential progression to multiple myeloma.

Main Methods:

  • Review of existing literature and case studies on primary amyloidosis.
  • Analysis of diagnostic markers including serum monoclonal protein and bone marrow biopsy.

Related Experiment Videos

  • Immunohistochemical and ultrastructural examination of tissue infiltrates.

    • Main Results:

    • Excess production of abnormal immunoglobulin light chains is the hallmark of primary amyloidosis.
    • Organ damage severity correlates with the extent of fibrillar protein infiltration.
    • Monoclonal protein in serum and specific bone marrow cellular infiltrates are key diagnostic indicators.

    Conclusions:

    • Primary amyloidosis is a complex plasma cell disorder with significant organ involvement.
    • Early identification of the underlying neoplasm is crucial for management.
    • A subset of patients may evolve into multiple myeloma over time.